Announcements Trials
Browse Landscape

Phase

Phase 3 13Phase 2/3 3Phase 2 3Phase NA 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Nausea 1Fallopian Tube Neoplasms 1Brenner Tumor 1

Interventions

Radiotherapy 10Early Intervention, Educational 7Standard of Care 6Magnetic Resonance Spectroscopy 6Interviews as Topic 6Educational Status 6Radiotherapy, Conformal 5Practice Guidelines as Topic 5Methods 5Cyclophosphamide 5Vincristine 4Psychiatric Rehabilitation 4Cisplatin 4Brachytherapy 4Biopsy 4Surgical Procedures, Operative 3Specimen Handling 3Radiosurgery 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Dexamethasone 3Counseling 3Carboplatin 3pegaspargase 2motexafin gadolinium 2etoposide phosphate 2Radiofrequency Ablation 2Radiation 2Preoperative Exercise 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NETWORK × dexamethasone 21-phosphate × Clear all
NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡